1 January 2012PatentsArchana Shanker

A step into the unknown: India's first compulsory license

The licence was granted to Natco Pharma, a generic drug company, for sorafenib tosylate, a life-extending drug developed, patented and launched by Bayer Corporation. This drug is sold under the trade name of Nexavar and is used for the treatment of advanced-stage kidney and liver cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Influential Women in IP

The real impact of judgments

1 December 2020 Justice Prabha Sridevan has left her mark on the Indian IP industry, first as a judge of the Madras High Court, and then as chair of the Intellectual Property Appellate Board. Here, she tells WIPR about two cases that she will always remember.

India e-commerce: Liability for platforms is coming at last

24 September 2019 India’s booming e-commerce industry has remained largely immune to the cries of rights owners, but not for much longer, explains Pravin Anand, Jaya Negi and Souradeep Mukhopadhyay.

Lululemon counsel on why Nike's 'Flyknit' claim construction faltered

Lenovo’s legal leader: We should be ‘enablers, not blockers’

Sterlington expands patent litigation team with new hire

‘Now is the time to scale rapidly’: Microsoft supports AI patent tool

WATCH: Engaging inventors to ensure you obtain the best IP

USPTO speeds up patent issuance amid widespread agency changes

Why recent ITC rulings are good news for SEP owners and the Commission

Why now is a good time to update your European patent strategy

A step into the unknown: India's first compulsory license

More on this story

Editor's picks

Editor's picks

More articles